Suppr超能文献

[家族性腺瘤性息肉病(FAP)患者的硬纤维瘤。来自海德堡息肉病登记处的临床及治疗观察]

[Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register].

作者信息

Kadmon M, Möslein G, Buhr H J, Herfarth C

机构信息

Chirurgische Klinik und Poliklinik, Universität Heidelberg.

出版信息

Chirurg. 1995 Oct;66(10):997-1005.

PMID:8529453
Abstract

The life-threatening event of early colorectal cancer in FAP patients may effectively be prevented by prophylactic colectomy. Desmoid tumors and periampullary carcinoma are now becoming the most frequent causes of death in FAP patients. Since the establishment of the Heidelberg polyposis registry in January 1991 we evaluated the frequency of desmoid tumors in 171 prospectively reexamined FAP patients. 29 patients (17%) with desmoid tumors were identified. In our series R0-resection with a wide security margin was performed in 12 cases, 3 of which developed a desmoid recurrence, 8 are free of desmoids and one treated for an intraabdominal desmoid states being well but refuses a radiological reevaluation. Tumor debulking was performed in 6 patients and led to an aggressive desmoid progression in 4 patients despite additional postoperative administration of tamoxifen and sulindac. Nonsurgical treatment with tamoxifen and sulindac seemed beneficial in 5 of 7 patients, 4 showed a stagnation of tumor growth, a reduction of an abdominal wall desmoid was documented in one female with a further intraabdominal desmoid. In life-threatening cases chemotherapy and radiation therapy may be considered. In two females radiation therapy resulted in a remarkable tumor reduction. The operative trauma of previous colectomy is considered the most relevant predisposing external factor inducing desmoid growth in FAP patients. 50% (11/22) of the desmoid tumors in our series were diagnosed within the first two years postoperatively, and 72% (18/22) of the desmoids developed within the first four years after colectomy.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

预防性结肠切除术可有效预防家族性腺瘤性息肉病(FAP)患者早期结直肠癌的危及生命事件。硬纤维瘤和壶腹周围癌如今正成为FAP患者最常见的死亡原因。自1991年1月海德堡息肉病登记处设立以来,我们评估了171例接受前瞻性复查的FAP患者中硬纤维瘤的发生率。确定了29例(17%)患有硬纤维瘤的患者。在我们的系列研究中,12例患者进行了切缘阴性且安全切缘较宽的R0切除,其中3例出现硬纤维瘤复发,8例未再出现硬纤维瘤,1例因腹腔内硬纤维瘤状态良好但拒绝影像学复查。6例患者进行了肿瘤减积手术,尽管术后额外给予他莫昔芬和舒林酸,但仍有4例患者出现硬纤维瘤侵袭性进展。他莫昔芬和舒林酸的非手术治疗似乎对7例患者中的5例有益,4例肿瘤生长停滞,1例女性腹壁硬纤维瘤缩小,同时还有一个腹腔内硬纤维瘤。在危及生命的情况下,可考虑化疗和放疗。两名女性接受放疗后肿瘤明显缩小。先前结肠切除术的手术创伤被认为是FAP患者诱发硬纤维瘤生长的最相关外部诱发因素。我们系列研究中50%(11/22)的硬纤维瘤在术后头两年内被诊断出,72%(18/22)的硬纤维瘤在结肠切除术后头四年内出现。(摘要截短于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验